These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 31286878

  • 1. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP, Oms M, Aklillu E, Kamuhabwa AAR.
    BMC Pregnancy Childbirth; 2019 Jul 08; 19(1):236. PubMed ID: 31286878
    [Abstract] [Full Text] [Related]

  • 2. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP, Minzi O, Mutagonda R, Baraka V, Mlugu EM, Aklillu E, Kamuhabwa AAR.
    Malar J; 2020 Apr 19; 19(1):160. PubMed ID: 32306955
    [Abstract] [Full Text] [Related]

  • 3. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK, Kalaji LN, Mbacham HF, Wepnje GB, Apinjoh TO, Ngole Sumbele IU, Dionne-Odom J, Tita ATN, Achidi EA.
    Malar J; 2020 Mar 02; 19(1):100. PubMed ID: 32122339
    [Abstract] [Full Text] [Related]

  • 4. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
    Kamga SLS, Ali IM, Ngangnang GR, Ulucesme MC, Keptcheu LTD, Keming EM, Tchuenkam VK, Foyet JV, Aktas M, Noubom M, Payne VK.
    Malar J; 2024 Jan 04; 23(1):6. PubMed ID: 38178125
    [Abstract] [Full Text] [Related]

  • 5. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.
    Cellich P, Unger HW, Rogerson SJ, Mola GDL.
    Malar J; 2024 Jul 05; 23(1):201. PubMed ID: 38970076
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
    Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL.
    Ann Trop Med Parasitol; 1998 Mar 05; 92(2):141-50. PubMed ID: 9625909
    [Abstract] [Full Text] [Related]

  • 7. Mefloquine for preventing malaria in pregnant women.
    González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C.
    Cochrane Database Syst Rev; 2018 Mar 21; 3(3):CD011444. PubMed ID: 29561063
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE, Chalwe V, Katalenich BL, Nambozi M, Mubikayi L, Mulele CK, Wiegand RE, Filler SJ, Kamuliwo M, Craig AS, Tan KR.
    Malar J; 2015 Feb 07; 14():69. PubMed ID: 25890159
    [Abstract] [Full Text] [Related]

  • 9. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Valea I, Tinto H, Drabo MK, Huybregts L, Henry MC, Roberfroid D, Guiguemde RT, Kolsteren P, D'Alessandro U, FSP/MISAME study Group.
    Malar J; 2010 Nov 12; 9():324. PubMed ID: 24576068
    [Abstract] [Full Text] [Related]

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D, Chilongola J, Ndeserua R, Mwingira F, Genton B.
    Trop Med Int Health; 2014 Sep 01; 19(9):1048-56. PubMed ID: 24965022
    [Abstract] [Full Text] [Related]

  • 12. Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
    Tarimo SD.
    East Afr J Public Health; 2007 Oct 01; 4(2):80-3. PubMed ID: 18085136
    [Abstract] [Full Text] [Related]

  • 13. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
    Agyeman YN, Newton S, Annor RB, Owusu-Dabo E.
    PLoS One; 2021 Oct 01; 16(4):e0250350. PubMed ID: 33878140
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
    Ndeserua R, Juma A, Mosha D, Chilongola J.
    Afr Health Sci; 2015 Sep 01; 15(3):810-8. PubMed ID: 26957969
    [Abstract] [Full Text] [Related]

  • 15. Mefloquine for preventing malaria in pregnant women.
    González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C.
    Cochrane Database Syst Rev; 2018 Nov 14; 11(11):CD011444. PubMed ID: 30480761
    [Abstract] [Full Text] [Related]

  • 16. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S, Coulibaly SO, Ouattara FT, D'Alessandro U.
    Trop Med Int Health; 2009 Feb 14; 14(2):174-82. PubMed ID: 19171009
    [Abstract] [Full Text] [Related]

  • 17. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V, Mbotwa CH, Zacharia A, Ambrose T, Moshi FV.
    Malar J; 2021 Feb 06; 20(1):75. PubMed ID: 33549094
    [Abstract] [Full Text] [Related]

  • 18. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E, Berens-Riha N, Pritsch M, Nwachuku N, Loescher T, Meremikwu M.
    Malar J; 2018 Jul 06; 17(1):251. PubMed ID: 29976228
    [Abstract] [Full Text] [Related]

  • 19. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG, Floyd J, Ter Kuile F, Cairns M.
    PLoS Med; 2017 Feb 06; 14(2):e1002243. PubMed ID: 28245259
    [Abstract] [Full Text] [Related]

  • 20. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P, Rovira-Vallbona E, Langa JS, Salvador C, Guetens P, Chiheb D, Xavier B, Kestens L, Enosse SM, Rosanas-Urgell A.
    Malar J; 2018 Mar 12; 17(1):109. PubMed ID: 29530044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.